|
CCDC91 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.500440E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.093580E-02 |
| Normal-vs-Stage2 |
4.967000E-01 |
| Normal-vs-Stage3 |
1.247750E-04 |
| Normal-vs-Stage4 |
2.628400E-04 |
| Stage1-vs-Stage2 |
2.539200E-01 |
| Stage1-vs-Stage3 |
2.767500E-02 |
| Stage1-vs-Stage4 |
4.514000E-02 |
| Stage2-vs-Stage3 |
1.126500E-02 |
| Stage2-vs-Stage4 |
2.534200E-02 |
| Stage3-vs-Stage4 |
9.579600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.556500E-04 |
| Normal-vs-AfricanAmerican |
5.539800E-02 |
| Normal-vs-Asian |
6.810700E-04 |
| Caucasian-vs-AfricanAmerican |
7.196800E-01 |
| Caucasian-vs-Asian |
4.882800E-01 |
| AfricanAmerican-vs-Asian |
4.178000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.558120E-02 |
| Normal-vs-Female |
1.721760E-03 |
| Male-vs-Female |
8.514000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.557900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.243990E-03 |
| Normal-vs-Age(61-80Yrs) |
1.199190E-03 |
| Normal-vs-Age(81-100Yrs) |
9.289500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.709800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.922640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.737600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.723000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.412800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.773400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.797800E-01 |
| Classical-VS-Follicular |
7.017700E-03 |
| Classical-VS-Other |
8.222000E-01 |
| Classical-VS-Normal |
1.982660E-03 |
| Tall-VS-Follicular |
1.564290E-03 |
| Tall-VS-Other |
6.241200E-01 |
| Tall-VS-Normal |
5.951600E-04 |
| Follicular-VS-Other |
3.183000E-01 |
| Follicular-VS-Normal |
9.659600E-01 |
| Other-VS-Normal |
1.206380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.980800E-03 |
| Normal-vs-N1 |
2.983200E-04 |
| N0-vs-N1 |
1.132630E-01 |
|
|
